Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01994382
Title Phase 1 Dose Escalation Study in Chronic Lymphocytic Leukemia and Non-hodgkin Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Portola Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Huntsville Alabama 35805 United States Details
Gilbert Arizona 85234 United States Details
Los Angeles California 90095 United States Details
Palo Alto California 94304 United States Details
Washington District of Columbia 20007 United States Details
Gainesville Florida 32608 United States Details
Sarasota Florida 34232 United States Details
Lawrenceville Georgia 30046 United States Details
Chicago Illinois 60637 United States Details
Louisville Kentucky 40207 United States Details
Baltimore Maryland 21229 United States Details
Ann Arbor Michigan 48109 United States Details
Hattiesburg Mississippi 39402 United States Details
Hackensack New Jersey 07601 United States Details
Morristown New Jersey 07960 United States Details
New York New York 10021 United States Details
Philadelphia Pennsylvania 19104 United States Details
Charleston South Carolina 29412 United States Details
Arlington Texas 76012 United States Details
Lubbock Texas 79410 United States Details
Richmond Virginia 23226 United States Details
Seattle Washington 98109 United States Details
Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field